Spero Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	40.27	52.89	76.33	109.11	112.58
Short-Term Investments	-	-	-	-	33.82
Cash & Short-Term Investments	40.27	52.89	76.33	109.11	146.4
Cash Growth	-23.87%	-30.71%	-30.04%	-25.47%	15.36%
Accounts Receivable	25.36	49.39	95.74	-	-
Other Receivables	0.03	3.09	1.55	1.08	2.64
Total Trade Receivables	25.39	52.48	97.29	1.08	2.64
Other Current Assets	1.63	1.91	4.18	3.38	8.83
Total Current Assets	67.29	107.28	131.21	113.57	157.87
Net Property, Plant & Equipment	1.48	3.11	4.16	5.49	7.56
Other Long-Term Assets	0.15	0.15	0.44	5.74	5.64
Total Assets	68.92	110.54	182.39	124.8	171.07
Accounts Payable	0.69	7.31	1.38	0.62	1.1
Accrued Expenses	5.58	17.72	6.56	8.97	14.35
Current Portion of Leases	1.96	1.75	1.72	1.69	1.36
Unearned Revenue	0.26	22.12	27.11	10.37	1.86
Other Current Liabilities	0.38	0.17	0.39	-	-
Total Current Liabilities	8.87	49.07	37.15	21.65	18.67
Long-Term Debt	-	-	-	-	48.41
Long-Term Leases	0.94	2.55	3.83	4.96	5.97
Other Long-Term Liabilities	0.09	12.8	34.52	22.26	9.73
Total Long-Term Liabilities	1.03	15.35	38.34	27.22	64.11
Total Liabilities	9.9	64.42	75.5	48.87	82.78
Preferred Stock	-	-	-	-	0
Common Stock	0.06	0.06	0.05	0.05	0.03
Additional Paid-in Capital	510.03	505.71	497.91	489.76	455.72
Accumulated Other Comprehensive Income	-	-	-	-	-0
Retained Earnings	-451.07	-459.64	-391.07	-413.88	-367.46
Shareholders' Equity	59.02	46.12	106.89	75.93	88.29
Total Liabilities & Equity	68.92	110.54	182.39	124.8	171.07
Total Debt	2.9	4.3	5.54	6.65	55.75
Net Cash (Debt)	37.37	48.59	70.79	102.46	90.65
Net Cash Growth	-23.09%	-31.36%	-30.91%	13.02%	-23.86%
Net Cash Per Share	0.63	0.90	1.34	2.73	2.93
Book Value	59.02	46.12	106.89	75.93	88.29
Book Value Per Share	1.00	0.85	2.02	2.02	2.86
Tangible Book Value	59.02	46.12	106.89	75.93	88.29
Tangible Book Value Per Share	1.00	0.85	2.02	2.02	2.86

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q